My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

12.77 -0.17 (-1.31%)
Streaming Delayed Price Updated: 10:23 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Forte Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences Tops Q2 Loss Forecasts
Via The Motley Fool
Topics Intellectual Property
Forte Biosciences, Inc. Announces Results and Provides Update
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Forte Biosciences Announces Pricing of $75 Million Public Offering
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Forte Biosciences Announces Proposed Public Offering
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Forte Biosciences, Inc. Announces Results and Provides Update
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
From Forte Biosciences, Inc.
Via Business Wire
Why Forte Biosciences (FBRX) Stock Is Trading Lower
Forte Biosciences shares are trading lower by 13.6% Monday afternoon. The company announced plans for the periodic resale of up to 9.5 million common stock shares by selling stockholders. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Forte Biosciences to Host R&D Day December 3, 2024
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Forte Biosciences Shares Are Soaring Today: What's Going On?
Forte Biosciences Inc. (NASDAQ: FBRX) shares are trading higher Wednesday. The company announced a $53 million private placement to fund the development of its autoimmune-focused drug candidate, FB102.... 
Via Benzinga
Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
 
Via Benzinga
Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views
 
Via Benzinga
US Stocks Mostly Lower; Target Posts Downbeat Earnings
 
Via Benzinga
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.